HbA1c News and Research

RSS
Children with type 1 diabetes benefit from rapid-acting insulin analogues; potential harm remains unclear

Children with type 1 diabetes benefit from rapid-acting insulin analogues; potential harm remains unclear

Physicians favor agents that can reduce HbA1c levels by 2% in diabetes patients

Physicians favor agents that can reduce HbA1c levels by 2% in diabetes patients

Roche discloses results of two of eight taspoglutide T-emerge phase III studies in diabetes patients

Roche discloses results of two of eight taspoglutide T-emerge phase III studies in diabetes patients

Fourth-quarter and full year fiscal 2009 results announced by Biodel

Fourth-quarter and full year fiscal 2009 results announced by Biodel

Majority of Canadians living with diabetes do not receive all clinical tests from health providers

Majority of Canadians living with diabetes do not receive all clinical tests from health providers

Report on the type 2 diabetes drug market in Brazil

Report on the type 2 diabetes drug market in Brazil

Roche announces results of phase III taspoglutide study in diabetes patients

Roche announces results of phase III taspoglutide study in diabetes patients

GI Dynamics to present interim data on its EndoBarrier Gastrointestinal Liner study

GI Dynamics to present interim data on its EndoBarrier Gastrointestinal Liner study

Gene variants which influence insulin metabolism can also affect birth weight

Gene variants which influence insulin metabolism can also affect birth weight

Enzo Biochem announces results of EGS21 clinical trial for treatment of non-alcoholic steatohepatitis

Enzo Biochem announces results of EGS21 clinical trial for treatment of non-alcoholic steatohepatitis

NCDP to help bring dramatic improvement in the prevention and care of diabetes

NCDP to help bring dramatic improvement in the prevention and care of diabetes

Roche discloses the results of first Phase III clinical study using Taspoglutide

Roche discloses the results of first Phase III clinical study using Taspoglutide

GI Dynamics’ EndoBarrier Gastrointestinal Liner for pre-surgical weight loss treatment demonstrates safety

GI Dynamics’ EndoBarrier Gastrointestinal Liner for pre-surgical weight loss treatment demonstrates safety

Orexigen Therapeutics announces new data from COR-I, COR-II and COR-Diabetes trials for Contrave

Orexigen Therapeutics announces new data from COR-I, COR-II and COR-Diabetes trials for Contrave

Liraglutide drug causes less nausea and hypoglycaemia compared to exenatide

Liraglutide drug causes less nausea and hypoglycaemia compared to exenatide

Bristol-Myers Squibb reports strong sales and earnings growth for third quarter 2009

Bristol-Myers Squibb reports strong sales and earnings growth for third quarter 2009

Positive results from Isis Pharmaceuticals' ISIS 113715 Phase 2 study in type 2 diabetes patients

Positive results from Isis Pharmaceuticals' ISIS 113715 Phase 2 study in type 2 diabetes patients

New results from ADVANCE provide important insights to reduce diabetes complications

New results from ADVANCE provide important insights to reduce diabetes complications

Study shows type 2 diabetes patients treated with ACTOplus met experience blood sugar reduction

Study shows type 2 diabetes patients treated with ACTOplus met experience blood sugar reduction

Dapagliflozin with metformin reduces glycosylated hemoglobin level and body weight

Dapagliflozin with metformin reduces glycosylated hemoglobin level and body weight